Insider Stock Trading History of Browne L Daniel


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Browne L Daniel since year 2005. The trader's CIK number is 1597583. At the time of this reporting, Browne L Daniel is the CEO and President of Revance Therapeutics, Inc. . (stock ticker symbol RVNC). See this page for all insider trading activities at Revance Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Browne L Daniel since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-18 RVNC Revance Therapeutics, Inc. Sale 7,662 26.16 200,407
2017-09-20 RVNC Revance Therapeutics, Inc. Sale 7,600 23.58 179,185
2017-08-23 RVNC Revance Therapeutics, Inc. Option Ex 331 2.55 844
2017-08-23 RVNC Revance Therapeutics, Inc. Sale 22,800 22.77 519,042
2017-06-12 RVNC Revance Therapeutics, Inc. Option Ex 8,300 2.55 21,165
2017-05-30 RVNC Revance Therapeutics, Inc. Option Ex 5,000 2.55 12,750
2017-05-24 RVNC Revance Therapeutics, Inc. Sale 19,713 20.35 401,100
2017-05-22 RVNC Revance Therapeutics, Inc. Sale 12,287 20.20 248,160
2017-02-22 RVNC Revance Therapeutics, Inc. Sale 11,037 20.63 227,649
2017-01-25 RVNC Revance Therapeutics, Inc. Sale 12,000 19.78 237,396
2016-12-28 RVNC Revance Therapeutics, Inc. Sale 12,000 20.94 251,256
2016-11-25 RVNC Revance Therapeutics, Inc. Sale 12,000 18.28 219,360
2016-10-26 RVNC Revance Therapeutics, Inc. Sale 12,000 14.85 178,200
2015-12-30 RVNC Revance Therapeutics, Inc. Option Ex 12,045 2.55 30,714
2014-11-28 RVNC Revance Therapeutics, Inc. Buy 6,000 16.67 100,020

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Browne L Daniel (CEO and President of Revance Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.